| Literature DB >> 29594096 |
Takahiro Tsukahara1,2, Takuma Sugahara2, Takuro Furusawa3, Francis Wanak Hombhanje4.
Abstract
BACKGROUND: In Papua New Guinea (PNG), a malaria treatment policy using rapid diagnostic tests (RDTs) plus artemisinin-based combination therapy (ACT) was widely introduced to rural communities in 2012. The objectives of the study were to evaluate the effect of this RDT/ACT introduction to a rural PNG population on health service utilization and to compare factors associated with health service utilization before and after the RDT/ACT introduction.Entities:
Keywords: antimalarials; delivery of health care; health service needs and demand; sex factors; treatment-seeking behavior
Year: 2018 PMID: 29594096 PMCID: PMC5859013 DOI: 10.3389/fpubh.2018.00075
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Descriptive statistics.
| Comparison group | Treated group | ||||
|---|---|---|---|---|---|
| ( | ( | ||||
| Variables | % | % | |||
| Health facility utilization | |||||
| Yes | 216 | 51.7 | 282 | 57.2 | 0.094 |
| No | 202 | 48.3 | 209 | 42.4 | |
| Missing | 0 | 0.0 | 2 | 0.4 | |
| Drug availability: yes | 281 | 67.2 | 403 | 81.7 | <0.001 |
| Direct cost (PNG Kina | 0 | 0–1 | 0 | 0–1 | <0.001 |
| Distance (km) | 0.70 | 0.26–1.18 | 0.84 | 0.21–1.61 | 0.493 |
| Age of patient (years) | 4 | 2–5 | 5 | 3–9 | <0.001 |
| Gender of patient: male | 215 | 51.4 | 257 | 52.1 | 0.834 |
| Illness severity | |||||
| Mild | 233 | 55.7 | 227 | 46.0 | <0.001 |
| Moderate | 113 | 27.0 | 181 | 36.7 | |
| Severe | 40 | 9.6 | 85 | 17.2 | |
| Missing | 32 | 7.7 | 0 | 0.0 | |
| Education of caretaker (years) | 6 | 6–8 | 6 | 6–8 | 0.953 |
| Missing | 23 | 5.5 | 0 | 0.0 | |
| Asset index | −0.312 | −0.91–0.58 | −0.312 | −0.91–0.33 | 0.805 |
| Missing | 5 | 1.2 | 8 | 1.6 | |
| Number of villages | 20 | 22 | |||
To compare the difference of variables between the comparison [before the introduction of rapid diagnostic test (RDT)/artemisinin-based combination therapy (ACT)] and treated (after the introduction of RDT/ACT) groups, chi square test was used for categorical variables and Wilcoxson rank-sum test was used for continuous variables.
.
.
.
.
Standardized differences of covariates.
| Standardized differences | ||
|---|---|---|
| Covariates | Unmatched | Matched |
| Antimalarial drug availability: yes | 0.325 | 0.008 |
| Direct cost (PNG Kina | −0.235 | −0.088 |
| Distance (km) | 0.092 | −0.017 |
| Age of patient (years) | 0.582 | −0.065 |
| Gender of patient: male | −0.019 | 0.102 |
| Illness severity: moderate | 0.182 | −0.005 |
| Illness severity: severe | 0.203 | 0.048 |
| Education of caretaker (years) | −0.058 | 0.040 |
| Asset index | −0.023 | −0.043 |
.
Estimation results of multilevel Poisson model.
| Model 1: pooled data | ||||||
|---|---|---|---|---|---|---|
| Fix variables | Prevalence ratio | 95% Confidence interval | ||||
| Treatment dummy (comparison = 0/treated = 1) | 1.07 | 0.92–1.24 | 0.38 | |||
| Drug availability (no = 0/yes = 1) | 1.02 | 0.83–1.25 | 0.84 | |||
| Direct cost (PNG Kina | 0.99 | 0.83–1.18 | 0.90 | |||
| Distance (km) | 0.88 | 0.84–0.93 | <0.001 | |||
| Age of patient (years) | 0.99 | 0.97–1.00 | 0.16 | |||
| Gender of patient (female = 0/male = 1) | 0.85 | 0.78–0.93 | <0.001 | |||
| Illness severity: moderate | 1.31 | 1.11–1.56 | 0.002 | |||
| Illness severity: severe | 1.51 | 1.22–1.87 | <0.001 | |||
| Education of caretaker (years) | 1.02 | 0.99–1.05 | 0.24 | |||
| Asset index | 1.00 | 0.93–1.07 | 0.98 | |||
| Intercept | 0.51 | 0.38–0.70 | <0.001 | |||
| Random variable | ||||||
| Village (variance of intercept) | 0.01 | 0.00–0.10 | ||||
| Number of individuals | 843 | |||||
| Number of villages | 24 | |||||
| Treatment dummy (comparison = 0/treated = 1) | ||||||
| Drug availability (no = 0/yes = 1) | 0.98 | 0.68–1.42 | 0.92 | 0.93 | 0.74–1.18 | 0.57 |
| Direct cost (PNG Kina | 1.24 | 0.90–1.71 | 0.19 | 0.91 | 0.78–1.06 | 0.21 |
| Distance (km) | 0.83 | 0.72–0.95 | 0.007 | 0.90 | 0.82–1.00 | 0.050 |
| Age of patient (years) | 0.98 | 0.95–1.01 | 0.11 | 0.99 | 0.98–1.01 | 0.42 |
| Gender of patient (female = 0/male = 1) | 0.86 | 0.76–0.98 | 0.020 | 0.83 | 0.71–0.97 | 0.022 |
| Illness severity: moderate | 1.32 | 1.06–1.64 | 0.013 | 1.32 | 1.07–1.62 | 0.009 |
| Illness severity: severe | 1.57 | 1.20–2.05 | 0.001 | 1.50 | 1.19–1.91 | 0.001 |
| Education of caretaker (years) | 1.03 | 0.97–1.09 | 0.30 | 1.02 | 0.99–1.05 | 0.25 |
| Asset index | 0.98 | 0.88–1.09 | 0.68 | 1.00 | 0.92–1.10 | 0.93 |
| Intercept | 0.49 | 0.32–0.75 | 0.001 | 0.59 | 0.43–0.81 | 0.001 |
| Random variable | ||||||
| Village (variance of intercept) | <0.001 | <0.001 | ||||
| Number of individuals | 360 | 483 | ||||
| Number of villages | 20 | 22 | ||||
The data collected before and after the introduction of rapid diagnostic test/artemisinin-based combination therapy were defined as comparison and treated groups, respectively.
Adjusted PR and 95% CI for fix variables and variance of intercept for a random variable are shown.
.
.